| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/21/2002 | CA2446555A1 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 11/21/2002 | CA2446266A1 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof |
| 11/21/2002 | CA2446180A1 Cytokine polypeptides |
| 11/21/2002 | CA2446166A1 Isolated human secreted proteins nucleic acid molecules encoding human secreted proteins and uses thereof |
| 11/21/2002 | CA2445494A1 Optimization of the molecular properties and formulation of proteins delivered by inhalation |
| 11/21/2002 | CA2445366A1 Molecules for disease detection and treatment |
| 11/21/2002 | CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 11/21/2002 | CA2443160A1 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 11/21/2002 | CA2442816A1 Human secreted proteins |
| 11/21/2002 | CA2442635A1 Gastrokines and derived peptides including inhibitors |
| 11/21/2002 | CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 11/20/2002 | EP1258530A2 Gaba-A receptor subunits (alpha-2, alpha-3, alpha-5, alpha -6, beta-2) and transfected cells expressing them |
| 11/20/2002 | EP1258529A2 FLIP Gene and FLIP Protein |
| 11/20/2002 | EP1258528A1 Expression of membrane proteins using an adenylyl cyclase of Mycobacterium tuberculosis |
| 11/20/2002 | EP1258497A2 Conjugates of factor VIII and a biocompatible polymer |
| 11/20/2002 | EP1258496A1 63751, Human sugar tranporter family member and uses therefor |
| 11/20/2002 | EP1258495A1 98359, A sodium channel beta 4 subunit, and uses therefor |
| 11/20/2002 | EP1258494A1 Multiprotein complexes from eukaryotes |
| 11/20/2002 | EP1258493A1 Cleavage and polyadenylation complex of precursor mRNA |
| 11/20/2002 | EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases |
| 11/20/2002 | EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker |
| 11/20/2002 | EP1257822A1 Her-2 binding antagonists |
| 11/20/2002 | EP1257817A2 Antigenic fragments associated with stress-induced proteins and their use as vaccines |
| 11/20/2002 | EP1257655A2 Transgenic plants having resistance to a fungal disease |
| 11/20/2002 | EP1257654A1 M cell directed vaccines |
| 11/20/2002 | EP1257651A2 Nucleic acids of the human abc1 gene and applications thereof |
| 11/20/2002 | EP1257649A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/20/2002 | EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 11/20/2002 | EP1257647A1 Control of membrane traffic |
| 11/20/2002 | EP1257646A2 Transporters and ion channels |
| 11/20/2002 | EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof |
| 11/20/2002 | EP1257643A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 11/20/2002 | EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses |
| 11/20/2002 | EP1257641A2 Method of modulating glycosylation pathways |
| 11/20/2002 | EP1257640A2 Nucleic acids and polypeptides of drosophila melanogaster snf sodium-neurotransmitter symporter family cell surface receptors and methods of use |
| 11/20/2002 | EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 11/20/2002 | EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines |
| 11/20/2002 | EP1257582A2 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 11/20/2002 | EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use |
| 11/20/2002 | EP1257580A2 Human ion channels |
| 11/20/2002 | EP1257579A2 Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
| 11/20/2002 | EP1257578A2 Transporters and ion channels |
| 11/20/2002 | EP1257577A2 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds |
| 11/20/2002 | EP1257576A1 Vasoactive intestinal peptide analogs |
| 11/20/2002 | EP1257575A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 11/20/2002 | EP1257574A1 Improved interleukin 10 |
| 11/20/2002 | EP1257573A2 New transcription factor carp-2 |
| 11/20/2002 | EP1257571A1 Method of purifying a hydrophobin present in a hydrophobin-containing solution |
| 11/20/2002 | EP1257570A2 Compounds for detection of infection by chlamydophila abortus |
| 11/20/2002 | EP1257569A2 Cold-adapted equine influenza viruses |
| 11/20/2002 | EP1257567A2 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 11/20/2002 | EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy |
| 11/20/2002 | EP1257564A1 Process of purification of hcg and recombinant hcg purified by that method |
| 11/20/2002 | EP1257561A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 11/20/2002 | EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 11/20/2002 | EP1257297A2 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 11/20/2002 | EP1257295A2 Factor vii or viia-like molecules |
| 11/20/2002 | EP1257291A1 Novel antibody with specificity for colon cancer |
| 11/20/2002 | EP1257289A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 11/20/2002 | EP1257287A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 11/20/2002 | EP1257286A2 Cancer treatment and prognosis involving hes-1 protein |
| 11/20/2002 | EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 11/20/2002 | EP1257167A1 Production of mammals which produce progeny of a single sex |
| 11/20/2002 | EP1206582A4 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 11/20/2002 | EP1018016B1 Immunoassay to detect human cytomegalovirus specific igm |
| 11/20/2002 | EP0984784B1 Anti-cancer products for treating cystic fibrosis |
| 11/20/2002 | EP0954326A4 A process for viral inactivation of lyophilized blood proteins |
| 11/20/2002 | EP0929812B1 Diagnostic agent and method to determine pregnancy in ruminants |
| 11/20/2002 | EP0832268B1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
| 11/20/2002 | EP0758394B1 Bifunctional protein, preparation and use |
| 11/20/2002 | EP0757721B1 Regulatory element conferring tapetum specificity |
| 11/20/2002 | EP0687303B1 Increase of the level of methionin in plant seeds by expression of 10kd zein from corn |
| 11/20/2002 | EP0652772B1 Herpesvirus vaccines |
| 11/20/2002 | EP0550506B1 Novel chemotactic factor |
| 11/20/2002 | CN1380422A Method for defining molecule being involved in adhesion and vaccine containing immunogenic peptide identified by said method |
| 11/20/2002 | CN1380419A Method for preparing human interleukin 4 by using gene engineering and its expression vector and engineering bacterium |
| 11/20/2002 | CN1380414A Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application |
| 11/20/2002 | CN1380392A Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application |
| 11/20/2002 | CN1380339A Mutational human gene nucleotide sequence coded polypeptide |
| 11/20/2002 | CN1380338A Human testis specific protein -16 gene coded protein |
| 11/20/2002 | CN1380337A A polypeptide-Down syndrome cell adhesion molecule homoplastic protein 1 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380336A A polypeptide-zinc finge protein-9.13 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380335A A polypeptide-glucosyltransferase protein-25.52 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380334A A polypeptide-ribosomal protein -10.23 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380333A A polypeptide-membrane protein 37.62 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380332A A polypeptide-ribbon protein 4.1 familia-14.85 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380331A A polypeptide-kinesin-38.28 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380330A A polypeptide-transposable factor-58.41 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380329A A polypeptide-zinc finger protein -56.87 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380328A A polypeptide-nuclear transformation protein -9.57 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380327A A polypeptide-anion-exchange protein -10.89 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380326A A polypeptide-sex-determining protein-85.69 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380325A A polypeptide-human large protein -60.17 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380324A A polypeptide-human large protein-76.01 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380323A A polypeptide-olfactory receptor protien -35.42 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380322A A polypeptide-cyclic AMP induced protein-55.11 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380321A A polypeptide-zine finger protein -59.18 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380320A A polypeptide-guanosine triphosphatase activator protein -10.01 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380319A A polypeptide-haematoglobin-9.24 and polynucleotide for coding this polypeptide |
| 11/20/2002 | CN1380318A A polypeptide-base mismatching correction protein-11.22 and polynucleotide for coding this polypeptide |